Tauroursodeoxycholic acid

Tauroursodeoxycholic acid is a lipid of Sterol Lipids (ST) class. Tauroursodeoxycholic acid is associated with abnormalities such as Hyperglycemia, Obesity, Wiskott-Aldrich Syndrome, neurogenic hypertension and Cholestatic liver disease. The involved functions are known as Cell Death, Apoptosis, Homeostasis, Process and mRNA Expression. Tauroursodeoxycholic acid often locates in Body tissue, Endoplasmic Reticulum, Hepatic, Blood and Protoplasm. The associated genes with Tauroursodeoxycholic acid are Homologous Gene and Mutant Proteins. The related lipids are cholanic acid, taurolithocholic acid 3-sulfate, Sterols, 7-dehydrocholesterol and tauromuricholic acid. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of Tauroursodeoxycholic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Tauroursodeoxycholic acid?

Tauroursodeoxycholic acid is suspected in Endothelial dysfunction, Hyperglycemia, Obesity, neurogenic hypertension, Cholestatic liver disease, Heart failure and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tauroursodeoxycholic acid

MeSH term MeSH ID Detail
Hypertension D006973 115 associated lipids
Insulin Resistance D007333 99 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with Tauroursodeoxycholic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Tauroursodeoxycholic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Tauroursodeoxycholic acid?

Disease model

Disease model are used in the study 'Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.' (Cortez LM et al., 2015).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Tauroursodeoxycholic acid

Download all related citations
Per page 10 20 50 100 | Total 531
Authors Title Published Journal PubMed Link
Shefer S et al. Regulation of cholesterol 7 alpha-hydroxylase by hepatic 7 alpha-hydroxylated bile acid flux and newly synthesized cholesterol supply. 1991 J. Biol. Chem. pmid:1993648
Nakai T et al. Microtubule-independent choleresis and anti-cholestatic action of tauroursodeoxycholate in colchicine-treated rat liver. 1992 Biochem. J. pmid:1361125
Häussinger D et al. Cell volume and bile acid excretion. 1992 Biochem. J. pmid:1463469
Thibault N and Ballet F Effect of bile acids on intracellular calcium in isolated rat hepatocyte couplets. 1993 Biochem. Pharmacol. pmid:8435088
Alvaro D et al. Effect of ursodeoxycholic acid on intracellular pH regulation in isolated rat bile duct epithelial cells. 1993 Am. J. Physiol. pmid:8238362
Beuers U et al. Effects of tauroursodeoxycholic acid on cytosolic Ca2+ signals in isolated rat hepatocytes. 1993 Gastroenterology pmid:8425704
Sano N et al. Estradiol-17 beta-glucuronide-induced cholestasis. Effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate. 1993 J. Hepatol. pmid:8445238
Shamburek RD and Schwartz CC Selective composition of biliary phosphatidylcholines is affected by secretion rate but not by bile acid hydrophobicity. 1993 J. Lipid Res. pmid:8263408
Beuers U et al. Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis. 1993 J. Clin. Invest. pmid:8254052
Pak JM and Lee SS Vasoactive effects of bile salts in cirrhotic rats: in vivo and in vitro studies. 1993 Hepatology pmid:8225224
Tsukahara K et al. Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats. 1993 Liver pmid:8259039
Ohiwa T et al. Tauroursodeoxycholate and tauro-beta-muricholate exert cytoprotection by reducing intrahepatocyte taurochenodeoxycholate content. 1993 Hepatology pmid:8383089
Bouchard G et al. Influence of oral treatment with ursodeoxycholic and tauroursodeoxycholic acids on estrogen-induced cholestasis in rats: effects on bile formation and liver plasma membranes. 1993 Liver pmid:8377596
Aldini R et al. Hepatic uptake and intestinal absorption of bile acids in the rabbit. 1994 Eur. J. Clin. Invest. pmid:7851470
Nguyen LB et al. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in the rat ileum: effects of bile acids and lovastatin. 1994 Metab. Clin. Exp. pmid:7968602
Kitani K et al. Tauro alpha-muricholate is as effective as tauro beta-muricholate and tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the rat. 1994 Hepatology pmid:8138240
Krähenbühl S et al. Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria. 1994 Hepatology pmid:7982660
Sakisaka S et al. Tubulovesicular transport of horseradish peroxidase in isolated rat hepatocyte couplets: effects of low temperature, cytochalasin B and bile acids. 1994 Hepatology pmid:7927203
Alvaro D et al. Functional and ultrastructural features of ethanol/bile salts interaction in the isolated perfused rat liver. 1995 Hepatology pmid:7705787
Sánchez Pozzi EJ et al. Differential effect of ursodeoxycholate and its taurine conjugate on biliary transport maximum of bilirubin in the rat. 1995 Life Sci. pmid:7643722
Groen AK et al. Regulation of protein secretion into bile: studies in mice with a disrupted mdr2 p-glycoprotein gene. 1995 Gastroenterology pmid:7498666
Rodrigues CM et al. Tauroursodeoxycholate increases rat liver ursodeoxycholate levels and limits lithocholate formation better than ursodeoxycholate. 1995 Gastroenterology pmid:7615207
Angelico M et al. N-ethyl-tauroursodeoxycholic acid, a novel deconjugation-resistant bile salt analogue: effects of acute feeding in the rat. 1995 Hepatology pmid:7657297
Ono T et al. Effect of tauroursodeoxycholic acid on bile flow and calcium excretion in ischemia-reperfusion injury of rat livers. 1995 J. Hepatol. pmid:8583148
Neuman MG et al. Effect of tauroursodeoxycholic and ursodeoxycholic acid on ethanol-induced cell injuries in the human Hep G2 cell line. 1995 Gastroenterology pmid:7615206
Takikawa H et al. Colchicine inhibits lithocholate-3-O-glucuronide-induced cholestasis in rats. 1995 J. Hepatol. pmid:7751593
Hillaire S et al. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture. 1995 Hepatology pmid:7601437
Azer SA et al. Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid. 1995 May-Jun J. Gastroenterol. Hepatol. pmid:7548801
Beuers U et al. Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. 1996 Gastroenterology pmid:8613063
Stravitz RT et al. Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7 alpha-hydroxylase. 1996 Am. J. Physiol. pmid:8770045
Muraca M et al. Protective effect of tauroursodeoxycholate against acute gastric mucosal injury induced by hydrophobic bile salts. 1996 Dig. Dis. Sci. pmid:8654150
Sugata K et al. Differential effects between tauroursodeoxycholic and taurochenodeoxycholic acids in hepatic fibrosis: an assessment by primary cultured Ito and Kupffer cells from the rat liver. 1996 J. Gastroenterol. Hepatol. pmid:8743917
Barone M et al. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies. 1996 Hepatology pmid:8621149
Albalak A et al. Effects of submicellar bile salt concentrations on biological membrane permeability to low molecular weight non-ionic solutes. 1996 Biochemistry pmid:8672496
Nebe B et al. Induction of a physical linkage between integrins and the cytoskeleton depends on intracellular calcium in an epithelial cell line. 1996 Exp. Cell Res. pmid:8940254
Groen AK et al. Control analysis of biliary lipid secretion. 1996 J. Theor. Biol. pmid:8944177
Van Erpecum KJ et al. Effects of bile salt hydrophobicity on crystallization of cholesterol in model bile. 1996 Eur. J. Clin. Invest. pmid:8864423
Heuman DM et al. Adsorption of mixtures of bile salt taurine conjugates to lecithin-cholesterol membranes: implications for bile salt toxicity and cytoprotection. 1996 J. Lipid Res. pmid:8728319
Setchell KD et al. Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis. 1996 Gut pmid:8675100
Bellentani S et al. Chronic administration of ursodeoxycholic and tauroursodeoxycholic acid changes microsomal membrane lipid content and fatty acid compositions in rats. 1996 Biochem. Biophys. Res. Commun. pmid:8607791
Crosignani A et al. Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response study. 1996 Dig. Dis. Sci. pmid:8674405
Klinkspoor JH et al. Mechanism of bile salt-induced mucin secretion by cultured dog gallbladder epithelial cells. 1996 Biochem. J. pmid:8670165
Takikawa H et al. Effects of ursodeoxycholate and its conjugates on biliary glutathione excretion in rats. 1996 Dig. Dis. Sci. pmid:8888706
Luk AS et al. Structural mechanisms of bile salt-induced growth of small unilamellar cholesterol-lecithin vesicles. 1997 Biochemistry pmid:9153403
Larghi A et al. Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study. 1997 Aliment. Pharmacol. Ther. pmid:9146783
van Nieuwerk CM et al. The role of bile salt composition in liver pathology of mdr2 (-/-) mice: differences between males and females. 1997 J. Hepatol. pmid:9148004
van de Heijning BJ et al. Membrane cholesterol content of cholesterol/phospholipid vesicles determines the susceptibility to both damage and protection by bile salts: implications for bile physiology. 1997 Eur J Gastroenterol Hepatol pmid:9187880
Setchell KD et al. Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei. 1997 Gastroenterology pmid:8978363
Gilani SS et al. Use of 1H NMR spectroscopy (T2 relaxation times) to examine the effects of conjugated ursodeoxycholic acid on phospholipid fluidity of human gallbladder bile. 1997 Biochem. Soc. Trans. pmid:9056921
Crocenzi FA et al. Role of bile salts in colchicine-induced hepatotoxicity. Implications for hepatocellular integrity and function. 1997 Toxicology pmid:9230445
Rao YP et al. Activation of protein kinase C alpha and delta by bile acids: correlation with bile acid structure and diacylglycerol formation. 1997 J. Lipid Res. pmid:9458268
Takikawa H et al. Absorption of unconjugated bile acids and tauroursodeoxycholate in the rat intestine. 1997 J. Gastroenterol. Hepatol. pmid:9504891
Balandraud-Pieri N et al. Effects of tauroursodeoxycholate solutions on cyclosporin A bioavailability in rats. 1997 Drug Metab. Dispos. pmid:9280397
Loria P et al. Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans. 1997 Hepatology pmid:9185744
Arrese M et al. Adaptive regulation of hepatic bile salt transport: role of bile salt hydrophobicity and microtubule-dependent vesicular pathway. 1997 J. Hepatol. pmid:9075679
Takikawa H et al. Effect of tauro-alpha-muricholate and tauro-beta-muricholate on oestradiol-17 beta-glucuronide-induced cholestasis in rats. 1997 J. Gastroenterol. Hepatol. pmid:9076630
Schliess F et al. Mitogen-activated protein kinases mediate the stimulation of bile acid secretion by tauroursodeoxycholate in rat liver. 1997 Gastroenterology pmid:9322526
Meier PJ et al. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. 1997 Hepatology pmid:9398014
Ishizaki K et al. Effect of sodium tauroursodeoxycholate (UR-906) on liver dysfunction in bile duct-ligated rats. 1997 Eur. J. Pharmacol. pmid:9314037
Beuers U Effects of bile acids on hepatocellular signaling and secretion. 1997 Jul-Aug Yale J Biol Med pmid:9626754
Roda A et al. Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the rat. 1998 Hepatology pmid:9462652
Sreejayan N and von Ritter C Effect of bile acids on lipid peroxidation: the role of iron. 1998 Free Radic. Biol. Med. pmid:9655521
Benz C et al. Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. 1998 J. Hepatol. pmid:9537871
Schroeder A et al. Substrate specificity of the rat liver Na(+)-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells. 1998 Am. J. Physiol. pmid:9486191
Peterson TC et al. The inhibitory effect of ursodeoxycholic acid and pentoxifylline on platelet derived growth factor-stimulated proliferation is distinct from an effect by cyclic AMP. 1998 Immunopharmacology pmid:9754904
Klinkspoor JH et al. Bile salts stimulate mucin secretion by cultured dog gallbladder epithelial cells independent of their detergent effect. 1998 Biochem. J. pmid:9576876
Vendemiale G et al. Ethanol-induced changes of intracellular thiol compartmentation and protein redox status in the rat liver: effect of tauroursodeoxycholate. 1998 J. Hepatol. pmid:9537863
Bouscarel B et al. Changes in G protein expression account for impaired modulation of hepatic cAMP formation after BDL. 1998 Am. J. Physiol. pmid:9696716
Yamaguchi Y et al. Taurin-conjugated ursodeoxycholic acid has a reversible inhibitory effect on human keratinocyte growth. 1998 J. Dermatol. Sci. pmid:9747660
Ono T et al. Tauroursodeoxycholic acid protects cholestasis in rat reperfused livers: its roles in hepatic calcium mobilization. 1998 Dig. Dis. Sci. pmid:9790455
Benz C et al. Effect of S-adenosylmethionine versus tauroursodeoxycholic acid on bile acid-induced apoptosis and cytolysis in rat hepatocytes. 1998 Eur. J. Clin. Invest. pmid:9726039
Funaoka M et al. Tauroursodeoxycholic acid enhances phagocytosis of the cultured rat Kupffer cell. 1999 J. Gastroenterol. Hepatol. pmid:10440209
Miyake H et al. Partial characterization of mechanisms of cytoprotective action of hydrophilic bile salts against hydrophobic bile salts in rats: relation to canalicular membrane fluidity and packing density. 1999 Dig. Dis. Sci. pmid:9952244
Milkiewicz P et al. Tauroursodeoxycholate and S-adenosyl-L-methionine exert an additive ameliorating effect on taurolithocholate-induced cholestasis: a study in isolated rat hepatocyte couplets. 1999 Hepatology pmid:9918924
Hertl M et al. Tauroursodeoxycholate ameliorates reperfusion injury after pig liver transplantation. 1999 Transpl. Int. pmid:10654358
Invernizzi P et al. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis. 1999 Hepatology pmid:9918905
Eckhardt U et al. Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells. 1999 Am. J. Physiol. pmid:10198348
Kurz AK et al. Phosphoinositide 3-kinase-dependent Ras activation by tauroursodesoxycholate in rat liver. 2000 Biochem. J. pmid:10926845
Falasca L et al. Tauroursodeoxycholate reduces ischemic damage in human allografts: a biochemical and ultrastructural study. 2000 Transplant. Proc. pmid:10700964
Benz C et al. Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes. 2000 Eur. J. Clin. Invest. pmid:10691996
Piazza F et al. Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid. 2000 Dig Liver Dis pmid:11515630
Rodrigues CM et al. Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition. 2000 J. Neurochem. pmid:11080188
Asamoto Y et al. Bile-salt hydrophobicity is a key factor regulating rat liver plasma-membrane communication: relation to bilayer structure, fluidity and transporter expression and function. 2001 Biochem. J. pmid:11672435
Ejiri S et al. Cellular distribution of thrombomodulin as an early marker for warm ischemic liver injury in porcine liver transplantation: protective effect of prostaglandin I2 analogue and tauroursodeoxycholic acid. 2001 Transplantation pmid:11330532
Moschetta A et al. Cholesterol crystallization in model biles: effects of bile salt and phospholipid species composition. 2001 J. Lipid Res. pmid:11483629
Kurz AK et al. Tauroursodesoxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats. 2001 Gastroenterology pmid:11487550
Ishizaki K et al. Effect of sodium tauroursodeoxycholate on phalloidin-induced cholestasis in rats. 2001 Eur. J. Pharmacol. pmid:11408049
Danchenko E et al. Effect of bile acids on the proliferative activity and apoptosis of rat hepatocytes. 2001 Exp. Toxicol. Pathol. pmid:11484843
Nathanson MH et al. Stimulation of ATP secretion in the liver by therapeutic bile acids. 2001 Biochem. J. pmid:11485545
Crocenzi FA et al. Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets. 2001 Hepatology pmid:11481618
Moschetta A et al. Hydrophilic bile salts enhance differential distribution of sphingomyelin and phosphatidylcholine between micellar and vesicular phases: potential implications for their effects in vivo. 2001 J. Hepatol. pmid:11394647
Fimognari C et al. Micronuclei induction, cell cycle delay and apoptosis as markers of cellular stress caused by ursodeoxycholic acid in human lymphocytes. 2001 Mutat. Res. pmid:11448637
Rodrigues CM et al. Amyloid beta-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate. 2001 Biochem. Biophys. Res. Commun. pmid:11181071
Colell A et al. Tauroursodeoxycholic acid protects hepatocytes from ethanol-fed rats against tumor necrosis factor-induced cell death by replenishing mitochondrial glutathione. 2001 Hepatology pmid:11679967
Keene CD et al. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease. 2001 Exp. Neurol. pmid:11573988
Ishigami F et al. Bile salt tauroursodeoxycholic acid modulation of Bax translocation to mitochondria protects the liver from warm ischemia-reperfusion injury in the rat. 2001 Transplantation pmid:11740392
Beuers U et al. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. 2001 Hepatology pmid:11343250
Chignard N et al. Bile acid transport and regulating functions in the human biliary epithelium. 2001 Hepatology pmid:11230727
Calmus Y and Podevin P Tauroursodeoxycholic acid for the cytoprotection of liver grafts during cold storage: a new aspect of its anti-apoptotic properties? 2001 Transplantation pmid:11408962
Falasca L et al. Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients. 2001 Transplantation pmid:11397961